Senti Biosciences Holdings SNTI
NASDAQ SNTI
$0.32 0.00 (-0.65%)
At close: Oct 2, 2026 · 4:00 PM EDT

Senti Biosciences Holdings (SNTI) Non-Current Deffered Revenue (2021 - 2022)

Updated

Senti Biosciences Holdings (SNTI) recorded Non-Current Deffered Revenue of $7.05 million in Q1 2022.

Analysis

Senti Biosciences Holdings (SNTI) Non-Current Deffered Revenue (2021 - 2022) Analysis & Trends

At the end of FY2021, Senti Biosciences Holdings reported Non-Current Deffered Revenue of $176,000.

  • Quarterly Non-Current Deffered Revenue has ranged from $176,000 in Q4 2021 to $8.05 million in Q3 2021 over the past five years.
  • Per Business Quant, the preceding three quarters came in at $176,000 (Q4 2021), $8.05 million (Q3 2021) and $8.05 million (Q2 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn -
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn -
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn -
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn -
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn -
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn -
10 Senti Biosciences Holdings 9.97 Mn 9.97 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 7.05 Mn
Dec 31, 2021 176,000.00
Sep 30, 2021 8.05 Mn
Jun 30, 2021 8.05 Mn
API Access

Senti Biosciences Holdings Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=SNTI&period=max&api_key=YOUR_API_KEY